Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

Trastuzumab 4 pertuzumab 2 Docetaxel 2 palbociclib 1 Protons 1 Paclitaxel 1 Letrozole 1 Fulvestrant 1 Fluorodeoxyglucose F18 1 Enfuvirtide 1 Doxorubicin 1 Cyclophosphamide 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × HER2-positive Breast Cancer × Enfuvirtide × Clear all

NCT02379585 2018-04-24

STEFNE

Western Regional Medical Center

Phase 1/2 Terminated

8 enrolled 1 chart

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡